Esteghamati Alireza, Malek Mojtaba, Hosseinpanah Ghasabeh Farhad, Hadaegh Farzad, Afkhami-Ardekani Mohammad, Aghai Meybodi Hamid Reza, Dabbaghmanesh Mohammad Hossein, Ghaemi Fatemeh, Jahed Seyed Adel, Kalbasi Saeed, Mehrdad Mojtaba, Mousavi Zohreh, Niafar Mitra, Rezvanian Hassan, Sanjari Mojgan, Ziaee Amir, Khamseh Mohammad E
Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
Med J Islam Repub Iran. 2025 Jan 21;39:13. doi: 10.47176/mjiri.39.13. eCollection 2025.
Type 2 diabetes mellitus (T2DM) is one of the most serious public health problems all over the world. Development of local consensus on management of T2DM, providing clinicians, researchers, and policymakers with updated and valid evidence in consideration of practical issues, is crucial. Therefore, we aimed to develop a consensus report on management of T2DM in Iran.
A task force group comprised of experts in diabetes management reviewed published literature. The task force members reached the majority agreement on all recommendations after participating in several group meeting discussions.
The consensus provided recommendations on diverse aspects on management of people with T2DM in Iran. The recommendations covered the following topics: first-line treatment, diabetes management in people with obesity, combination therapy in people with T2DM, injectable therapy, and non-alcoholic fatty liver in people with T2DM.
Considering evidence-based guidelines, the task force group developed a consensus to address important clinical issues in the management of people with T2DM in Iran.
2型糖尿病(T2DM)是全球最严重的公共卫生问题之一。就T2DM的管理达成地方共识,为临床医生、研究人员和政策制定者提供考虑实际问题的最新有效证据至关重要。因此,我们旨在制定一份关于伊朗T2DM管理的共识报告。
一个由糖尿病管理专家组成的特别工作组审查了已发表的文献。特别工作组成员在参加了几次小组会议讨论后,就所有建议达成了多数共识。
该共识就伊朗T2DM患者管理的各个方面提供了建议。这些建议涵盖以下主题:一线治疗、肥胖人群的糖尿病管理、T2DM患者的联合治疗、注射治疗以及T2DM患者的非酒精性脂肪肝。
考虑到循证指南,特别工作组制定了一项共识,以解决伊朗T2DM患者管理中的重要临床问题。